Stage IV Lung Cancer: Joanne's Patient Story

Patient Info: Joanne Sabol, Female, 60s | Stage IV

Metastatic Site: abdomen

More than 2 years after starting pembrolizumab for recurrent Stage IV lung cancer, Joanne had an 81% tumor reduction and continued to feel well while remaining on treatment.

Memorial Sloan KetteringRead more →

Stage I Non-Small Cell Lung Cancer: Robert's Survivor Story

Patient Info: Robert Tumanic, Male | Stage I

After SBRT, follow-up scans showed the treated tumors resolved and no additional tumors requiring treatment; as of May 2019, the treated sites were stable and no further lung-cancer therapy was required.

Stage III KRAS Lung Cancer: Bill's Survivor Story

Patient Info: Bill Morris, Male | Stage III

Biomarkers: KRAS

After multimodal treatment, Bill had remained actively cancer-free for more than 3 years and used his experience to support other patients.

Lung Cancer: Bob's Patient Story

Patient Info: Bob Neary, Male, 60s

Bob died from lung cancer in February 2013 at age 63, 7 months after diagnosis.

GO2 FoundationRead more →

Small Cell Lung Cancer: Nina's Patient Story

Patient Info: Nina, Female

Nina’s tumors began shrinking within weeks of starting trial immunotherapy, and she remained on the trial for 3 years without treatment side effects.

Stage IV Lung Cancer: Carla's Patient Story

Patient Info: Carla, Female | Stage IV

Metastatic Site: brain

After repeated resistance and a serious episode involving a brain lesion and extensive fluid around the lung, Carla recovered and was stable without new symptoms on her eighth line of treatment.

Stage IV Lung Cancer: Mary's Patient Story

Patient Info: Mary Lynn Moser, Female | Stage IV

Metastatic Site: brain

Mary Lynn wrote this message before her death after nearly 10 years with lung cancer and more than 5 years with brain metastases, while receiving aggressive immunotherapy and chemotherapy.

Stage IV EGFR Non-Small Cell Lung Cancer: Valerie's Patient Story

Patient Info: Valerie Brown, Female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion

Valerie was stable for more than 20 months on targeted therapy for Stage IV EGFR exon 19-deleted lung adenocarcinoma.

Stage IV ALK Lung Cancer: Frank's Survivor Story

Patient Info: Frank Sierawski, Male | Stage IV

Biomarkers: ALK-positive

Frank was disease-free for more than 7 years while continuing his second ALK-targeted tyrosine kinase inhibitor after lobectomy and brain radiation.

Stage IV ALK Lung Cancer: Michelle's Patient Story

Patient Info: Michelle, Female | Stage IV

Biomarkers: ALK-positive

Metastatic Site: leptomeninges and cerebrospinal fluid / central…

Targeted therapy and proton craniospinal irradiation eliminated detectable leptomeningeal disease. Treatment side effects later passed, and Michelle continued rehabilitation.

Lung Cancer: Mary's Patient Story

Patient Info: Mary, Female

Mary received 4 cycles of chemotherapy, then radiotherapy and a clinical trial for lung cancer, while using MyChristie-MyHealth questionnaires to keep her clinical team updated between visits.

The Christie NHSRead more →

Stage IV Lung Cancer: Thierry's Survivor Story

Patient Info: Thierry, Male, 50s | Stage IV

Metastatic Site: Brain

Thierry had lung cancer with a brain metastasis treated with urgent brain surgery, radiotherapy, chemotherapy, and lung tumor surgery; later he lived under close surveillance after seizures and treatment-related recovery.

Lung Cancer: Liz's Survivor Story

Patient Info: Liz, Female, 40s

Liz’s localized lung cancer was treated with surgery, chemotherapy, and 6 weeks of radiotherapy; by January 2016 her follow-up assessment was clear.

Inoperable small cell lung cancer with brain metastases and treatment response

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: Brain

After chemotherapy, radiation, and adjunct metabolic/complementary measures, the patient’s lung tumor shrank by 24%, later brain metastases disappeared on control scan, and arm function improved.

Aggressive lung cancer with bone metastases and concurrent localized breast cancer

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: Bone: skull, spine, clavicle

The patient was still receiving carboplatin and Taxol for aggressive lung cancer with bone metastases, while her caregiver reported rapid clinical improvement, pain relief, disappearance of a visible forehead metastasis, and 1 cm reduction in a concurrent localized breast tumor.

Lung Cancer: François's Survivor Story

Patient Info: François, Male, 60s

François completed 20 radiation sessions and 6 chemotherapy sessions for lung cancer diagnosed in 2010 and later continued routine hospital checks every 6 months.

Stage IV ALK Non-Small Cell Lung Cancer: Suzanne's Patient Story

Patient Info: Suzanne, Female | Stage IV

Biomarkers: ALK mutation identified on tissue biopsy; blood biomarker test was negative

Metastatic Site: Not specified

Stage IV ALK-positive lung cancer was stable for almost 4 years on alectinib before progression in mid-2023; Suzanne moved to brigatinib and radiation and was working toward stability again.

Lung Cancer Research FoundationRead more →

Stage IV Non-Small Cell Lung Cancer: Amy's Patient Story

Patient Info: Amy, Female | Stage IV

Metastatic Site: Neck lymph node; bones — hips, femurs, foot; adrenal…

Living 5 years after Stage IV squamous NSCLC diagnosis, after Keytruda did not work and treatment included bone radiation, SBRT to the lung nodule, and adrenal cryoablation.

Lung Cancer Research FoundationRead more →

Stage III ROS1 Non-Small Cell Lung Cancer: Wendy's Survivor Story

Patient Info: Wendy, Female | Stage III

Biomarkers: ROS1-positive / ROS1-rearranged

Completed chemoradiation, surgery, and post-surgery radiation for Stage III ROS1-positive NSCLC by January 2017 and later shared a long-term survivor/advocacy story; no explicit NED statement is given.

Lung Cancer Research FoundationRead more →

Stage IV KRAS Non-Small Cell Lung Cancer: Maureen's Patient Story

Patient Info: Maureen, Female | Stage IV

Biomarkers: KRAS mutation

Metastatic Site: Not reported

Living with KRAS-mutated Stage IV lung cancer after initial Stage I diagnosis, later surgery, and radiation, while remaining active in KRAS and lung cancer advocacy.

Lung Cancer Research FoundationRead more →

Laura Greco: Stage IV Lung Cancer

Patient Info: Laura Greco, Female | Stage IV

Biomarkers: ALK translocation / ALK-driven; MET amplification; EGFR amplification reported in brain tumor

Metastatic Site: Brain

Laura Greco passed away on July 14, 2024 after Stage IIIA ALK-driven lung cancer later metastasized to the brain and required repeated brain-directed treatment and targeted therapy.

Lung Cancer Research FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Rhonda's Patient Story

Patient Info: Rhonda Martin, Female | Stage IV

Biomarkers: EGFR-positive mutation

Metastatic Site: Brain; spine; hip bone; lymph nodes; cerebrospinal…

Rhonda Martin passed away on January 9, 2023 from complications of Stage IV EGFR-positive lung cancer, nearly 5 years after diagnosis in March 2018.

Lung Cancer Research FoundationRead more →

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →